Epithelial-to-Mesenchymal Transition in Diabetic Nephropathy: Fact or Fiction?

The pathophysiology of diabetic nephropathy (DN), one of the most serious complications in diabetic patients and the leading cause of end-stage renal disease worldwide, is complex and not fully elucidated. A typical hallmark of DN is the excessive deposition of extracellular matrix (ECM) proteins in...

Full description

Bibliographic Details
Main Authors: Loeffler, Ivonne, Wolf, Gunter
Format: Online
Language:English
Published: MDPI 2015
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4695850/
id pubmed-4695850
recordtype oai_dc
spelling pubmed-46958502016-01-19 Epithelial-to-Mesenchymal Transition in Diabetic Nephropathy: Fact or Fiction? Loeffler, Ivonne Wolf, Gunter Review The pathophysiology of diabetic nephropathy (DN), one of the most serious complications in diabetic patients and the leading cause of end-stage renal disease worldwide, is complex and not fully elucidated. A typical hallmark of DN is the excessive deposition of extracellular matrix (ECM) proteins in the glomerulus and in the renal tubulointerstitium, eventually leading to glomerulosclerosis and interstitial fibrosis. Although it is obvious that myofibroblasts play a major role in the synthesis and secretion of ECM, the origin of myofibroblasts in DN remains the subject of controversial debates. A number of studies have focused on epithelial-to-mesenchymal transition (EMT) as one source of matrix-generating fibroblasts in the diseased kidney. EMT is characterized by the acquisition of mesenchymal properties by epithelial cells, preferentially proximal tubular cells and podocytes. In this review we comprehensively review the literature and discuss arguments both for and against a function of EMT in renal fibrosis in DN. While the precise extent of the contribution to nephrotic fibrosis is certainly arduous to quantify, the picture that emerges from this extensive body of literature suggests EMT as a major source of myofibroblasts in DN. MDPI 2015-10-09 /pmc/articles/PMC4695850/ /pubmed/26473930 http://dx.doi.org/10.3390/cells4040631 Text en © 2015 by the authors; licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/4.0/).
repository_type Open Access Journal
institution_category Foreign Institution
institution US National Center for Biotechnology Information
building NCBI PubMed
collection Online Access
language English
format Online
author Loeffler, Ivonne
Wolf, Gunter
spellingShingle Loeffler, Ivonne
Wolf, Gunter
Epithelial-to-Mesenchymal Transition in Diabetic Nephropathy: Fact or Fiction?
author_facet Loeffler, Ivonne
Wolf, Gunter
author_sort Loeffler, Ivonne
title Epithelial-to-Mesenchymal Transition in Diabetic Nephropathy: Fact or Fiction?
title_short Epithelial-to-Mesenchymal Transition in Diabetic Nephropathy: Fact or Fiction?
title_full Epithelial-to-Mesenchymal Transition in Diabetic Nephropathy: Fact or Fiction?
title_fullStr Epithelial-to-Mesenchymal Transition in Diabetic Nephropathy: Fact or Fiction?
title_full_unstemmed Epithelial-to-Mesenchymal Transition in Diabetic Nephropathy: Fact or Fiction?
title_sort epithelial-to-mesenchymal transition in diabetic nephropathy: fact or fiction?
description The pathophysiology of diabetic nephropathy (DN), one of the most serious complications in diabetic patients and the leading cause of end-stage renal disease worldwide, is complex and not fully elucidated. A typical hallmark of DN is the excessive deposition of extracellular matrix (ECM) proteins in the glomerulus and in the renal tubulointerstitium, eventually leading to glomerulosclerosis and interstitial fibrosis. Although it is obvious that myofibroblasts play a major role in the synthesis and secretion of ECM, the origin of myofibroblasts in DN remains the subject of controversial debates. A number of studies have focused on epithelial-to-mesenchymal transition (EMT) as one source of matrix-generating fibroblasts in the diseased kidney. EMT is characterized by the acquisition of mesenchymal properties by epithelial cells, preferentially proximal tubular cells and podocytes. In this review we comprehensively review the literature and discuss arguments both for and against a function of EMT in renal fibrosis in DN. While the precise extent of the contribution to nephrotic fibrosis is certainly arduous to quantify, the picture that emerges from this extensive body of literature suggests EMT as a major source of myofibroblasts in DN.
publisher MDPI
publishDate 2015
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4695850/
_version_ 1613518196250247168